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Short Title: Alu Polymorphisms, Discrimination, and Blood Pressure 
 
Abstract African Americans are 40% more likely to be afflicted with hypertension in 
comparison to non-Hispanic, white Americans, resulting in a 30% higher instance of 
mortality due to cardiovascular disease. There is debate about the relative contributions of 
genetic and sociocultural risk factors to the racial disparity in hypertension. 
 We assayed three Alu insertion polymorphisms located in the angiotensin-1-converting 
enzyme (ACE), tissue plasminogen activator (PLAT), and with no-lysine kinase 1 (WNK1) 
genes. We also estimated West African genetic ancestry and developed novel measures of 
perceived discrimination to create a biocultural model of blood pressure among African-
American adults in Tallahassee, FL (n=158). 
 When tested separately, the ACE Alu non-insertion allele was significantly associated 
with higher systolic and diastolic blood pressure. In multiple regression analyses, West 
African genetic ancestry was not associated with blood pressure and reduced the strength of 
all blood pressure models tested. A gene x environment interaction was identified between 
the ACE Alu genotype and a new measure of unfair treatment that includes experiences by 
individuals close to the study participant. Inclusion of the WNK1 Alu genotype further 
improved this model of blood pressure variation. 
 Our results suggest an association of the ACE and WNK1 genotypes with blood pressure 
that is consistent with their proposed gene functions. Perceived unfair treatment (to others) 
shows a threshold effect where an increase in blood pressure is demonstrated at higher 
values. The interaction between the ACE genotype and unfair treatment highlights the 
benefits of including both genetic and cultural data to investigate complex disease. 
 
African Americans experience a disproportionate burden of the morbidity of hypertension in 
the United States and are 40% more likely than non-Hispanic, white Americans to be 
hypertensive (Office of Minority Health 2014). In order to improve our understanding of the 
etiology of racial disparities in hypertension, we present a biocultural approach, wherein 
both genetic and sociocultural risk factors are measured.  
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 Alu insertion polymorphisms are transposable, repeated elements of ~300 nucleotides 
that often demonstrate linkage disequilibrium with causative alleles for common diseases 
and have the potential to causatively disrupt the function of genes through alternative 
splicing and modified expression and regulation (Deininger and Batzer 1999; Putku et al. 
2011). Alu polymorphisms assayed in this study were chosen based on two criteria: 1) 
previous findings of association with hypertension in European populations and, where 
available, African American populations and 2) a viable physiological mechanism to explain 
an effect on blood pressure regulation. 
 The ACE Alu polymorphism is a 287 base pair insertion in intron 16 of the angiotensin-
1-converting enzyme (ACE) gene (Asamoah et al. 1996). Inclusion of the ACE Alu accounts 
for 45-50% of the variation in in vivo levels of circulating angiotensin-I-converting enzyme 
(ACE) (Jern et al. 1999). ACE is the rate-limiting enzyme in the renin-angiotensin system 
(RAS), cleaving angiotensin I to angiotensin II (Ajala et al. 2012). Angiotensin II is the 
catalyzing agent of most of the action of the RAS, resulting in vasoconstriction via the 
inactivation of bradykinin. The ACE Alu non-insertion allele is generally associated with 
higher ACE plasma levels and, therefore, increased systolic and diastolic blood pressure 
(Ajala et al. 2012; Asamoah et al. 1996; Das et al. 2008; Hooper et al. 2002; Rotimi et al. 
1996; Woo et al. 2012). However, a few studies have found the insertion allele to be 
associated with hypertension (Ismail et al. 2004; Panjaliya et al. 2013). 
 The PLAT Alu polymorphism is a 311 base pair insertion located on intron 8 of the 
PLAT gene (Tishkoff et al. 2000). The insertion allele is associated with increased tissue 
plasminogen activator (TPA) release in vivo (Jern et al. 1999). TPA is a serine protease that 
enzymatically cleaves plasminogen to activated plasmin (Jern et al. 1999), and plasmin is an 
enzyme that proteolyzes fibrin, the major structural component in blood clots (Ladenvall et 
al. 2003). Heightened plasma levels of TPA result in greater binding with plasminogen 
activator inhibitor-1 (PAI-1), which inhibits fibrinolysis (Valle-Garay et al. 2013). 
Therefore, the insertion allele has been associated with thrombosis, stroke, and adverse 
cardiovascular events (Valle-Garay et al. 2013). 
 The AluYb8 insertion is a 300 base pair insertion within intron 10 of the with no-lysine 
kinase 1 (WNK1) gene. WNK1 is a serine/threonine kinase that regulates the co-
transportation of sodium and potassium ions within the distal nephron convoluted tubule and 
collecting duct (Vidal-Petiot et al. 2013). WNK1 has been identified as a locus of blood 
pressure regulation due to association with Familial hyperkalemic hypertension, or 
Gordon’s Syndrome, an uncommon form of hypertension in humans. This condition is 
linked to up-regulation of WNK1 gene activity, which increases ion activity and induces 
vasoconstriction (Vidal-Petiot et al. 2013). The insertion allele is associated with higher 
blood pressure and is found at significantly lower frequencies in sub-Saharan African 
populations than other ethnic groups (Putku et al. 2011). 
 Genetic ancestry is often included in a discussion of racial health disparities with an 
implicit assumption that genetic ancestry is associated in some manner with disease risk. 
Genetic ancestry is estimated using ancestry-informative markers (AIMs) that display large 
frequency differences between putative parental populations. Studies have found 
associations between West African genetic ancestry and disease phenotypes, including 
elevated serum creatinine (Peralta et al. 2010), increased risk of insulin resistance but not 
hypertension or body mass index (BMI) (Reiner et al. 2007), and BMI and higher bone 
mineral density (Fernández et al. 2003). However, these studies did not explain the 
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biological underpinning of such associations and did not include sociocultural variables that 
might be more relevant to an understanding of racial disparities in disease and related 
phenotypes.  
 Blood pressure has been associated with a range of sociocultural factors, including 
socioeconomic status (Cundiff et al. 2015) and psychosocial stressors (Dressler 1999). Some 
researchers have proposed that social stressors associated with systemic racism constitute 
unique stressors that contribute to excess hypertension among African Americans (Williams 
and Jackson 2005). However, most existing studies measure perceived discrimination only 
by reference to participants' personal exposure to unfair treatment. Dressler (1999) 
emphasizes that stress models should be informed by careful ethnographic work. In the first 
phase of our research, ethnographic interviews revealed that many study participants 
mentioned unfair treatment experienced by others – family, close friends, co-workers – 
when given open-ended questions querying their experiences with discrimination. Thus, in 
the second, survey phase of our research, we included standard measures of perceived 
discrimination, or unfair treatment (Williams and Jackson 2005; Williams et al. 1997), and 
developed novel measures to capture unfair treatment experienced by individuals close to 
the study participants. 
  Most research on the risk factors associated with high blood pressure seldom includes 
both genetic and sociocultural data, such that few studies are able to evaluate the relative 
importance of genetic versus sociocultural factors or to test for gene x environment 
interactions. In our study, three Alu polymorphisms were assayed as candidate genetic 
variants for hypertension in 158 individuals. Genetic ancestry was estimated from 1423 
assayed AIMs. Sociocultural variables included novel measures of unfair treatment 
experienced by individuals close to the study participants, i.e. unfair treatment to others.  
 
MATERIALS AND METHODS 
Participant Selection. Data come from a multistage probability sample of African 
American adults in Tallahassee, FL (Table 1). We first stratified Census block groups using 
cluster analysis of neighborhood-level indicators of racial composition and material 
deprivation to maximize contrasts in relevant social stressors. Using data from the U.S. 
Census Bureau’s American Community Survey, the cluster analysis was based on the 
following variables for Census Block Groups: percent of residents who identified as Black 
or African American, percent of residents with high school diploma or equivalent, percent 
of female-headed households, percent of vacant housing units, percent in poverty, median 
household income. Next, within each cluster, we randomly selected block groups and then 
residential addresses within sampled block groups. Last, we randomly selected one 
participant from among eligible adults (self-identified African American, age 25-65) in each 
household. The participant from each household was chosen beforehand so as not to bias the 
sample in favor of ambulatory individuals (those individuals more likely to come to the 
door). The final number of individuals with complete data for analyses reported here was 
158. The research protocol was approved by the University of Florida IRB-01 (#364-2008) 
and IRB-02 (#2007-U-469). Informed consent was obtained from all participants prior to 
data collection. 
Saliva Samples. Saliva samples were collected and stored using Oragene DNA 
Collection Kits (DNA Genotek, Ontario, Canada). DNA was extracted according to the 
manufacturer’s protocol. 
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Genotyping the Alu Markers. Samples were individually genotyped for each of the 
three Alu polymorphisms: ACE, PLAT, WNK1. Primers for each Alu polymorphism insertion 
were designed based on previously published literature (Ajala et al. 2012; Hooper et al. 
2002; Putku et al. 2011). PCR was performed with 2 µL DNA, 10 µL H2O, 12.5 µL Apex™ 
RED Taq DNA Polymerase Master Mix 2.0X (Genesee, San Diego, CA), and 0.5 µL of the 
respective 10 µM primers/ reaction for 35 cycles: 94°C (5 min) and 94°C (30 sec), 58°C (30 
sec), 72°C (30 sec). Amplicons were electrophoresed on 2% agarose gels. Insertion and non-
insertion allele sizes were 490bps and 190bps, respectively for the ACE Alu insertion, 
420bps/110bps for the PLAT Alu insertion, and 660bps/ 353bps for the WNK1 Alu insertion. 
African Ancestry. Ancestry informative markers (AIMs) were identified from the 
Illumina African American Admixture panel (Illumina, San Diego, CA) and were genotyped 
using a custom Affymetrix Axiom Array that we designed (Affymetrix, Santa Clara, CA). 
Ultimately, 1423 AIMs had a genotyping success rate ≥ 95% and were used to estimate 
genetic ancestry. West African ancestry estimates for each of the African American study 
participants were generated using a Bayesian model with prior allele frequencies in the 
ADMIXMAP program (Hoggart et al. 2004). Prior allele frequencies were derived from the 
HapMap Yoruba (YRI) and CEPH European (CEU) populations in a two way model of 
admixture. YRI and CEU populations were selected to approximate the parental populations 
from which the admixture in our sample population was derived and while this selection 
will influence the relative proportion of ancestry estimated for admixed individuals, it is not 
expected to significantly influence the ancestry associations tested in our analyses. 
 We also used the AIMs to test if relatedness of the study participants influenced the 
results in our final model. To account for relatedness in our samples, we generated a matrix 
of pairwise relatedness estimates (IBD) for all possible pairs of individuals in our cohort 
using the genotypes of the ancestry informative markers (AIMs). We used this matrix to 
estimate the random effects of relatedness in a Q-K mixed model framework using the 
GLIMMIX procedure in SAS (Yu et al. 2006). 
Sociocultural and Biological Data. Sociocultural and biological data were obtained during 
face-to-face interviews in participants' homes. Three resting blood pressure readings were 
collected using a standardized protocol in which respondents were seated for approximately 
30 minutes and had not consumed alcohol or tobacco. Blood pressure was measured using 
an oscillometric monitor (UA-787, A&D Medical, Tokyo, Japan) that had been validated 
according to the European Society of Hypertension protocol (Longo et al. 2003). The first 
readings differed significantly from the latter two readings and, thus, an average of the latter 
two readings was used in the study analyses. Weight and height were measured using a 
digital scale and portable stadiometer and used to calculate BMI. Data on age, sex, 
antihypertensive medication use, years of education, and perceived discrimination were 
collected throughout the interview. 
 In the first phase of our research (in preparation), we conducted in-depth ethnographic 
interviews with 34 African Americans from varying socioeconomic backgrounds. Many 
respondents narrated their experiences of racism by citing the experiences of others, e.g. 
close friends, family, and coworkers. In the survey phase, on which this paper is based, we 
adapted a standard measure of perceived discrimination (Williams et al. 1997, Williams and 
Jackson 2005) that usually asks only about respondents' own experiences in nine social 
domains (e.g., police, courts, housing). We modified these questions to ask if "you or 
someone close to you" had been treated unfairly in each domain. If participants answered 
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"yes", we subsequently asked who had experienced the unfair treatment given the following 
options—yourself, your spouse, your parents, your child, your grandchild, a sibling, another 
relative, or a close friend. The discrimination scales used in our study included: any/major 
instances of unfair treatment experienced by the study participant during their lifetime 
(UT_Self) and any/major lifetime unfair treatment experienced by individuals close to the 
study participant (UT_Other). Unfair treatment was measured as an unweighted count of 
affirmative answers to the questions of unfair treatment in nine social domains with a 
maximum theoretical value of nine (actual range = 0-7; Table 1). 
Statistical Analysis The presence of each Alu insertion was tested individually with systolic 
and diastolic blood pressure using association analyses. Two-way ANOVA analyses were 
used to test for a significant difference between the mean blood pressure values for each Alu 
insertion genotypic group. To determine a possible trend based on the number of insertion 
alleles, pairwise comparisons of the genotypic groups (Tukey’s test) were performed. 
 Multiple linear regression models were constructed using R statistical software (R Core 
Team 2013) to test the association of combinations of the following variables with blood 
pressure levels: Alu polymorphisms, West African ancestry, years of education, household 
income, and measures of perceived unfair treatment as well as standard covariates of age, 
sex, BMI, and antihypertensive medication. 
 
RESULTS 
Genotype data for the ACE, PLAT, and WNK1 Alu polymorphisms and medical and 
sociocultural data were collected on 158 individuals (Table 1). We first tested for 
association of the individual Alu insertion alleles and genotypes with blood pressure. The 
only significant association was found with the ACE Alu insertion allele (p=0.007134 for 
systolic and p=0.01098 for diastolic blood pressure) and ACE genotypes (p=0.0145 for 
systolic, p=0.0083 for diastolic). A Tukey’s test showed that one non-insertion allele 
increased systolic blood pressure by about ~0.1 mmHg, and a second non-insertion allele 
increased blood pressure by ~9.9 mmHg. For diastolic blood pressure one non-insertion 
allele led to an increase of ~2.2 mmHg per ACE Alu non-insertion allele, and a second non-
insertion allele increased blood pressure by ~5.3 mmHg. 
 Multiple linear regression was next used to gain a more comprehensive picture of the 
variables that influence blood pressure. We first identified the optimal base model to explain 
blood pressure variation based on previously identified co-variates (e.g. age, sex, BMI, 
antihypertensive medication). The base model was then used to test the effect of the three 
Alu polymorphisms, West African genetic ancestry, two measures of unfair treatment and 
two measures of socioeconomic status (years of education and household income). 
Identification of the optimal base model and comparison of subsequent models was based 
on lower Akaike information criterion (AIC) and higher R2 values. 
 The optimal base model for systolic blood pressure included age, sex, BMI, and 
antihypertensive medication use (Table 2). The optimal model for diastolic blood pressure 
included age, sex and BMI, but did not include antihypertensive medication use 
(Supplementary Table 1). Measures intended to capture socioeconomic status, such as years 
of education and household income, did not improve the model (Years education-AIC: 
926.65, R2: 0.2233, p-value: 0.65036; household income- AIC: 926.86, R2: 0.2223, p-value: 
0.93698). West African ancestry was found to reduce the strength of all models tested (e.g. 
base model: AIC: 926.82, R2: 0.2186, p-value: 0.84773). The ACE Alu polymorphism was 
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the only genetic marker to improve the model on its own with a modest improvement of 
both AIC and R2 values (Table 2).  
 Neither of the unfair treatment measures improved the model on their own. However, an 
interaction between the ACE Alu genotype and unfair treatment experienced by individuals 
close to the study participant (UT_Other) improved the model (Table 2). UT_Other was 
reported by 68.35 % of study participants, demonstrating its salience to participants’ 
experiences of unfair treatment, with affirmative responses ranging from zero to seven 
(Figure 1). All categories of “Other” individuals had multiple responses, demonstrating that 
all categories were relevant to the measure of unfair treatment by others (Figure 2). 
 Although the interaction between the ACE Alu genotype and UT_Other did improve the 
model, the interaction effect was not significant. However, we noticed a possible threshold 
effect of unfair treatment on systolic blood pressure at UT_Other ≥ 3 (Supplementary Figure 
1). Thus, we dichotomized the UT_Other variable into low (0-2) and high levels (3-7) of 
unfair treatment, which resulted in an improvement on the previous best model and the ACE 
Alu  x UT_Other interaction became significantly associated with blood pressure (Table 2). 
Furthermore, the ACE Alu x UT_Other interaction showed a gene x environment effect such 
that only the non-insertion homozygous individuals demonstrated increased blood pressure 
with increased unfair treatment (Figure 3).  
 After refining the optimal model to include the interaction between ACE Alu and 
UT_Other, we tested to see if the other two Alu markers improved the model. We found that 
WNK1 Alu improved the model and was significantly associated with systolic blood 
pressure (Table 2).  
 We then tested to see if relatedness between participants influenced our results, 
specifically the significance of the ACE Alu x UT_Other interaction in the optimal model. 
We ran a Q-K mixed model that included age, sex, BMI, antihypertensive medication, ACE 
Alu genotype, WNK1 Alu genotype, UT_Other (high-low), and ACE Alu genotype x 
UT_Other (high-low) interaction and the relatedness matrix. This analysis identified that the 
interaction effect between ACE Alu genotype and UT_Other (high-low) remained significant 
even after accounting for relatedness (p-value of 0.0037).  
 It is important to note that the model improvements listed above reflect only modest 
improvements in the AIC and R2 values. Nevertheless, the best model of variation for both 
systolic and diastolic blood pressure consisted of the base model plus the ACE Alu 
genotype, WNK1 Alu genotype, UT_Other, and ACE Alu genotype x UT_Other interaction. 
The statistical significance of the association of the ACE Alu genotype x UT_Other 
interaction is especially compelling given the relatively small sample size of our study. 
 
DISCUSSION 
Over the years, lengthy debate has surrounded the factors that influence blood pressure and, 
more specifically, the role of these factors in the racial disparity that exists in hypertension. 
Similarly, there has been debate on the role of the ACE Alu polymorphism in blood pressure 
variation. Seemingly contradictory articles have suggested the presence and absence of the 
insertion allele to be factors in cardiovascular disease morbidity. More recent studies have 
hypothesized that some of the conflict might signal varying degrees of linkage 
disequilibrium between the phenotypic trait locus and the ACE Alu polymorphism in 
different racial or ethnic groups (Reiner et al. 2007). When limiting the focus to African 
American populations, greater consensus exists for the association of increased blood 
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pressure with the non-insertion allele, although few evaluations of the ACE Alu 
polymorphism in African Americans have been conducted within the past decade (Reiner et 
al. 2007). Our study provides clarification of the ACE Alu association. Specifically, we find 
a significant and cumulative effect of the non-insertion allele with higher blood pressure, i.e. 
one non-insertion allele increased systolic blood pressure by ~0.1 mmHg, and a second non-
insertion allele increased blood pressure by ~9.9 mmHg. As the non-insertion allele has 
been found to be associated with higher ACE activity and subsequently greater conversion 
to angiotensin-II and bradykinin inactivation, our results are consistent with the predicted 
physiological mechanism of ACE (Ajala et al. 2012). 
 To better understand the ACE Alu polymorphism’s contribution to hypertension, we 
explored its effect in combination with two other Alu polymorphisms of interest, PLAT and 
WNK1. In this context, we found that the WNK1 Alu genotype significantly improved the 
model of blood pressure variation when added in combination with the ACE Alu x 
UT_Other interaction. This result suggests an association between ACE and WNK1 gene 
functions. Studies of the WNK family of genes have determined their key role in vascular 
tonus (Zeniya et al. 2015). Angiotensin II, the product of ACE action, has been determined 
to regulate the WNK3 and WNK4 genes, which are involved in a phosphorylating cascade 
that leads to vasoconstriction and vascular tone (Zeniya et al. 2015). Although the role of the 
WNK1 gene in this mechanism has not been well studied, a recent study implicated its 
function in the regulation of vascular tension in coordination with WNK4 (Susa et al. 2012). 
Our results showing involvement of both ACE and WNK1 Alu polymorphisms provide 
support for a possible biological interaction of angiotensin II with the WNK1 
phosphorylation cascade that ultimately results in vasoconstriction. Furthermore, our study 
confirms results of previous studies of the WNK gene family, which elucidate the linkage 
between the renin-angiotensin and ion regulation systems in hypertension. 
 With the study of racial health disparities, incorporation of genetic ancestry seems an 
intuitive improvement from the previous system of racial self-identification. Several studies 
of African American populations have demonstrated associations of disease-related 
phenotypes with African ancestry (Fernández et al. 2003; Peralta et al. 2010; Reiner et al. 
2007). In contrast, our study found no association of West African ancestry with either 
systolic or diastolic blood pressure and West African ancestry reduced the strength of all the 
models of blood pressure variation in this study. Our result undermines the validity of 
genetic ancestry as a risk factor for hypertension and its perceived role in contributing to the 
disparity of hypertension in African Americans. Instead, we suggest that sociocultural 
measures designed to capture the unique stressors for African Americans, such as 
experiences of unfair treatment, may better reflect the race-specific risk factors associated 
with hypertension. 
 The interaction between the ACE Alu genotype and unfair treatment to others 
(UT_Others) reflects the complex nature of the impact of discrimination on blood pressure 
in a population that demonstrates disparities in hypertension. Interestingly, an increase in 
blood pressure was only seen in the at-risk non-insertion homozygous individuals when 
UT_Others reached levels of three or greater. This result is consistent with the “weathering 
hypothesis,” which proposes a threshold of experienced discrimination before effects on 
physical and biological health are observed (Geronimus et al. 2006). The accumulated, 
larger allostatic load, i.e. wear and tear on the body due to repeated or chronic stress, in 
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African Americans has been suggested to be a contributing factor in racial health disparities 
(Geronimus et al. 2006). 
 It is interesting to speculate on why unfair treatment to others is a salient measure of 
stress and why it appears to have a larger effect on blood pressure than unfair treatment to 
self. Stress exposures are typically measured by eliciting participant’s perceptions of 
stressors. The focus on the individual is limited because it neglects social and cultural 
context and because people vary in their ability or willingness to report on their own 
stressful experiences (Young 1980; Dressler 2007). These limitations may be especially 
significant in trying to measure exposure to social stressors such as racial discrimination 
(as opposed to, say, stressful life events) because participants may be reluctant to report 
personal experiences of unfair treatment in order to avoid the stigma of discrimination. It 
may be less threatening to report on others’ discrimination experiences, such that this 
measure yields less-biased measures of participant’s exposures. Furthermore, denying 
that one has experienced discrimination could itself be a copying strategy. Finally, people 
may feel they have more control over things that they experience personally, whereas it 
may be more stressful to hear about bad experiences happening to people close to them 
over which they have little control. Regardless, the key consideration is that activation of 
physiological responses to stress does not require direct experience of a particular 
stressor. The same responses can be activated by vicarious exposure to the stressor. 
Furthermore, people who have higher exposure to vicarious racism may be more likely to 
suffer anticipatory stress responses or to perceive ambiguous situations as discriminatory 
when they enter social contexts where friends or family have been treated unfairly.  
 Our study highlights how a biocultural approach can provide a more complete 
understanding of complex diseases, such as hypertension. Our results would not have been 
detected without inclusion of both genetic and cultural data. Specifically, we identified an 
interaction between the ACE Alu polymorphism and unfair treatment to others and the 
WNK1 Alu polymorphism that improved our model of blood pressure variation. Our finding 
that only the measure of unfair treatment to others, i.e. not unfair treatment to self, improved 
the model demonstrates the value of novel measures of discrimination and suggests that the 
biological consequences of discrimination experiences are complex and not well 
understood. Further study is warranted to better understand the effects that genes and social 
stressors, like discrimination, have on disease outcomes, possibly leading to the 
manifestation of apparent genetic predispositions and contributing to racial disparities in 
health that persist today. 
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Table 1. Characteristics of study sample 
Characteristics	 Total/Mean	(SD)1	
N	 158	
Men:Women	 51:107	
Age	(years)	 40.96	(11.90)	
Body	mass	index	 32.47	(9.40)	
Antihypertensive	medication	(yes:no)	 48:110	
Systolic	BP	 128.51	(20.91)	
Diastolic	BP	 81.38	(13.26)	
Education	(years)	 13.15	(2.40)	
African	ancestry	 0.89	(0.072)	
UT_Other	 1.48	(1.57)	
UT_Other	(range)	 0-7	
 
1SD = standard deviation 
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Table 2: Optimal model choice using multiple linear regression analysis of systolic blood 
pressure 
Model	 Variable	 β 	Coefficient	 P-value	 AIC	 R
2
adj	
Base	 Age	(Years)	 0.418	 0.002	 924.86	 0.227	
	 Sex	(1=male,	2=female)	 -14.769	 1.19E-05	 	  
 BMI	 0.634	 0.00061	 	  
		 BP	Meds	 5.366	 0.167	 		 		
ACE	 Age	(Years)	 0.422	 0.00168	 922.9	 0.2415	
	 Sex	(1=male,	2=female)	 -14.424	 1.61E-05	 	  
 BMI	 0.624	 0.00067	 	  
 BP	Meds	 4.422	 0.254	 	  
		 ACE	genotype	 -4.184	 0.0513	 		 		
ACE-UT_Other	WNK1	 Age	(Years)	 0.389	 0.0037	 920.95	 0.2642	
	 Sex	(1=male,	2=female)	 -15.0211	 6.09E-06	 	  
 BMI	 0.0597	 0.0007	 	  
 BP	Meds	 5.303	 0.168	 	  
 ACE	genotype	 -1.602	 0.57243	 	  
 WNK1	Genotype	 9.04049	 0.04517	 	  
 UT_Other	 0.09854	 0.96601	 	  
		 I(ACE*UT_Other)	 -2.04096	 0.13869	 		 		
ACE-UT_Other	WNK11	 Age	(Years)	 0.409	 0.00307	 916.03	 0.2868	
	 Sex	(1=male,	2=female)	 -14.455	 1.10E-05	 	  
 BMI	 0.574	 0.00086	 	  
 BP	Meds	 5.3185	 0.21554	 	  
 ACE	genotype	 -2.2318	 0.39264	 	  
 WNK1	Genotype	 7.4704	 0.08787	 	  
 UT_Other	 4.854	 0.35144	 	  
		 I(ACE*UT_Other)	 -13.5557	 0.0096	 		 		
 
 
1 Uses the dichotomized high/low UT_Other variable. 
2 A P value of 0.01 was considered significant after multiple comparison testing using a 
Bonferroni correction of 0.05/5 (5 = 3 Alu polymorphisms and 2 unfair treatment measures). 
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Supplementary Table 1: Multiple linear regression model of diastolic blood pressure 
 
Model	 Variable	 β 	Coefficient	 P-value	 AIC	 R2adj	
Base	 Age	(Years)	 0.17401	 0.0388	 800.21	 0.122	
	 Sex	(1=male,	2=female)	 -5.11427	 0.0214	 	  
		 BMI	 0.47008	 3.29E-05	 		 		
ACE	 Age	(Years)	 0.16718	 0.0441	 796.67	 0.146	
	 Sex	(1=male,	2=female)	 -4.88444	 0.0259	 	  
 BMI	 0.44654	 6.56E-05	 	  
		 ACE	genotype	 -3.32142	 0.0208	 		 		
ACE-UT_Other	WNK1	 Age	(Years)	 0.1519	 0.07	 798.1	 0.154	
	 Sex	(1=male,	2=female)	 -5.10741	 0.0198	 	  
 BMI	 0.44858	 5.80E-05	 	  
 ACE	genotype	 -1.61949	 0.3993	 	  
 WNK1	Genotype	 4.3832	 0.1517	 	  
 UT_Other	 0.37208	 0.6955	 	  
		 I(ACE*UT_Other)	 -1.32503	 0.1572	 		 		
ACE-UT_Other	WNK11	 Age	(Years)	 0.15174	 0.0681	 796.51	 0.163	
	 Sex	(1=male,	2=female)	 -4.82416	 0.0267	 	  
 BMI	 0.43428	 9.24E-05	 	  
 ACE	genotype	 -2.19434	 0.1622	 	  
 WNK1	Genotype	 3.52438	 0.2402	 	  
 UT_Other	 2.90159	 0.4148	 	  
		 I(ACE*UT_Other)	 -6.99061	 0.0589	 		 		
 
1 Uses the dichotomized high/low UT_Other variable. 
2 A P value of 0.01 was considered significant after multiple comparison testing using a 
Bonferroni correction of 0.05/5 (5 = 3 Alu polymorphisms and 2 unfair treatment measures). 
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Figure Legends 
 
Figure 1. Distribution of affirmative responses concerning unfair treatment experienced by 
individuals close to the study participant. The range of affirmative responses is shown on 
the X axis and the total number of individuals who reported 0-7 experiences is shown on the 
Y axis.  
 
Figure 2. Distribution of individuals close to the study participant who experienced unfair 
treatment in the nine query areas (Unfair treatment on the job, by the police, by the courts, at 
school, obtaining housing, through the banking system, through the health care system, 
receiving service, e.g. from a mechanic, and from in-laws). Total number of affirmative 
answers is plotted on the Y axis. 
 
Figure 3. Interaction of ACE Alu genotype and UT_Other (coded as high/low) with systolic 
blood pressure. 
 
Supplementary Figure 1. Interaction of ACE Alu genotype and UT_Other (coded as 0-7) 
with systolic blood pressure. A threshold effect of unfair treatment on blood pressure is seen 
at UT_Other ≥ 3. 
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